nodes	percent_of_prediction	percent_of_DWPC	metapath
Trametinib—CYP2C8—Montelukast—allergic rhinitis	0.0918	0.152	CbGbCtD
Trametinib—CYP2C8—Loratadine—allergic rhinitis	0.0918	0.152	CbGbCtD
Trametinib—CYP3A4—Flunisolide—allergic rhinitis	0.0648	0.107	CbGbCtD
Trametinib—CYP3A4—Olopatadine—allergic rhinitis	0.061	0.101	CbGbCtD
Trametinib—CYP2C8—Hydrocortisone—allergic rhinitis	0.0511	0.0845	CbGbCtD
Trametinib—CYP3A4—Loratadine—allergic rhinitis	0.0372	0.0616	CbGbCtD
Trametinib—CYP3A4—Montelukast—allergic rhinitis	0.0372	0.0616	CbGbCtD
Trametinib—CYP3A4—Methylprednisolone—allergic rhinitis	0.0341	0.0564	CbGbCtD
Trametinib—CYP2C8—Dexamethasone—allergic rhinitis	0.0318	0.0526	CbGbCtD
Trametinib—CYP3A4—Triamcinolone—allergic rhinitis	0.0258	0.0427	CbGbCtD
Trametinib—CYP3A4—Betamethasone—allergic rhinitis	0.0221	0.0367	CbGbCtD
Trametinib—CYP3A4—Prednisolone—allergic rhinitis	0.0218	0.0362	CbGbCtD
Trametinib—CYP3A4—Hydrocortisone—allergic rhinitis	0.0207	0.0343	CbGbCtD
Trametinib—CYP3A4—Dexamethasone—allergic rhinitis	0.0129	0.0213	CbGbCtD
Trametinib—MAP2K2—TSLP Signaling Pathway—TSLP—allergic rhinitis	0.00665	0.0636	CbGpPWpGaD
Trametinib—MAP2K1—TSLP Signaling Pathway—TSLP—allergic rhinitis	0.00622	0.0595	CbGpPWpGaD
Trametinib—MAP2K1—respiratory system—allergic rhinitis	0.00471	0.146	CbGeAlD
Trametinib—MAP2K1—eye—allergic rhinitis	0.00431	0.133	CbGeAlD
Trametinib—MAP2K2—respiratory system—allergic rhinitis	0.00415	0.129	CbGeAlD
Trametinib—MAP2K1—epithelium—allergic rhinitis	0.00394	0.122	CbGeAlD
Trametinib—MAP2K1—skin of body—allergic rhinitis	0.00375	0.116	CbGeAlD
Trametinib—MAP2K2—bronchus—allergic rhinitis	0.00341	0.106	CbGeAlD
Trametinib—MAP2K2—skin of body—allergic rhinitis	0.0033	0.102	CbGeAlD
Trametinib—MAP2K2—Fc-epsilon receptor I signaling in mast cells—MS4A2—allergic rhinitis	0.0031	0.0296	CbGpPWpGaD
Trametinib—MAP2K2—CXCR3-mediated signaling events—CCL11—allergic rhinitis	0.00292	0.0279	CbGpPWpGaD
Trametinib—MAP2K1—Fc-epsilon receptor I signaling in mast cells—MS4A2—allergic rhinitis	0.0029	0.0277	CbGpPWpGaD
Trametinib—MAP2K1—CXCR3-mediated signaling events—CCL11—allergic rhinitis	0.00273	0.0261	CbGpPWpGaD
Trametinib—MAP2K1—lung—allergic rhinitis	0.0025	0.0775	CbGeAlD
Trametinib—MAP2K2—TSLP Signaling Pathway—CCL11—allergic rhinitis	0.00246	0.0235	CbGpPWpGaD
Trametinib—MAP2K1—TSLP Signaling Pathway—CCL11—allergic rhinitis	0.0023	0.022	CbGpPWpGaD
Trametinib—MAP2K2—lung—allergic rhinitis	0.0022	0.0683	CbGeAlD
Trametinib—MAP2K2—Endothelins—CYSLTR1—allergic rhinitis	0.00202	0.0193	CbGpPWpGaD
Trametinib—MAP2K1—Endothelins—CYSLTR1—allergic rhinitis	0.00189	0.018	CbGpPWpGaD
Trametinib—MAP2K2—Toll-like Receptor Signaling Pathway—TLR1—allergic rhinitis	0.00167	0.016	CbGpPWpGaD
Trametinib—MAP2K2—Interleukin-2 signaling—IL5—allergic rhinitis	0.00166	0.0159	CbGpPWpGaD
Trametinib—MAP2K1—Toll-like Receptor Signaling Pathway—TLR1—allergic rhinitis	0.00157	0.015	CbGpPWpGaD
Trametinib—MAP2K1—Osteopontin Signaling—NFKB1—allergic rhinitis	0.00156	0.0149	CbGpPWpGaD
Trametinib—MAP2K1—Interleukin-2 signaling—IL5—allergic rhinitis	0.00155	0.0149	CbGpPWpGaD
Trametinib—MAP2K2—Axon guidance—PFN2—allergic rhinitis	0.00142	0.0136	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—PFN2—allergic rhinitis	0.00133	0.0127	CbGpPWpGaD
Trametinib—MAP2K2—Fc epsilon receptor (FCERI) signaling—MS4A2—allergic rhinitis	0.00132	0.0126	CbGpPWpGaD
Trametinib—MAP2K2—Regulation of toll-like receptor signaling pathway—TLR1—allergic rhinitis	0.00131	0.0125	CbGpPWpGaD
Trametinib—MAP2K1—Fc epsilon receptor (FCERI) signaling—MS4A2—allergic rhinitis	0.00124	0.0118	CbGpPWpGaD
Trametinib—MAP2K1—Regulation of toll-like receptor signaling pathway—TLR1—allergic rhinitis	0.00122	0.0117	CbGpPWpGaD
Trametinib—MAP2K2—TCR Signaling Pathway—IL17A—allergic rhinitis	0.00106	0.0102	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—PFN2—allergic rhinitis	0.00101	0.00968	CbGpPWpGaD
Trametinib—MAP2K1—TCR Signaling Pathway—IL17A—allergic rhinitis	0.000995	0.00951	CbGpPWpGaD
Trametinib—MAP2K2—TGF-beta Signaling Pathway—FOXP3—allergic rhinitis	0.000994	0.0095	CbGpPWpGaD
Trametinib—MAP2K2—Interleukin-11 Signaling Pathway—ICAM1—allergic rhinitis	0.00099	0.00947	CbGpPWpGaD
Trametinib—MAP2K1—Estrogen signaling pathway—NFKB1—allergic rhinitis	0.000985	0.00942	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—PFN2—allergic rhinitis	0.000947	0.00906	CbGpPWpGaD
Trametinib—MAP2K1—TGF-beta Signaling Pathway—FOXP3—allergic rhinitis	0.00093	0.00889	CbGpPWpGaD
Trametinib—MAP2K1—Interleukin-11 Signaling Pathway—ICAM1—allergic rhinitis	0.000926	0.00886	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by Interleukins—IL5—allergic rhinitis	0.000854	0.00817	CbGpPWpGaD
Trametinib—MAP2K1—AGE/RAGE pathway—SMAD3—allergic rhinitis	0.000834	0.00798	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by Interleukins—IL5—allergic rhinitis	0.000799	0.00764	CbGpPWpGaD
Trametinib—MAP2K1—RANKL/RANK Signaling Pathway—ICAM1—allergic rhinitis	0.000775	0.00741	CbGpPWpGaD
Trametinib—MAP2K2—Gastrin-CREB signalling pathway via PKC and MAPK—CYSLTR1—allergic rhinitis	0.000755	0.00722	CbGpPWpGaD
Trametinib—MAP2K1—Gastrin-CREB signalling pathway via PKC and MAPK—CYSLTR1—allergic rhinitis	0.000706	0.00675	CbGpPWpGaD
Trametinib—MAP2K1—Interleukin-1 signaling—NFKB1—allergic rhinitis	0.000633	0.00605	CbGpPWpGaD
Trametinib—MAP2K2—TSLP Signaling Pathway—NFKB1—allergic rhinitis	0.000595	0.00569	CbGpPWpGaD
Trametinib—MAP2K2—Structural Pathway of Interleukin 1 (IL-1)—NFKB1—allergic rhinitis	0.000595	0.00569	CbGpPWpGaD
Trametinib—MAP2K2—Ceramide signaling pathway—NFKB1—allergic rhinitis	0.000585	0.00559	CbGpPWpGaD
Trametinib—MAP2K1—Senescence and Autophagy in Cancer—SMAD3—allergic rhinitis	0.000575	0.0055	CbGpPWpGaD
Trametinib—MAP2K1—Aryl Hydrocarbon Receptor—NFKB1—allergic rhinitis	0.000566	0.00541	CbGpPWpGaD
Trametinib—MAP2K1—Structural Pathway of Interleukin 1 (IL-1)—NFKB1—allergic rhinitis	0.000556	0.00532	CbGpPWpGaD
Trametinib—MAP2K1—TSLP Signaling Pathway—NFKB1—allergic rhinitis	0.000556	0.00532	CbGpPWpGaD
Trametinib—MAP2K1—Ceramide signaling pathway—NFKB1—allergic rhinitis	0.000547	0.00523	CbGpPWpGaD
Trametinib—MAP2K2—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—allergic rhinitis	0.00053	0.00506	CbGpPWpGaD
Trametinib—MAP2K2—Cardiac Hypertrophic Response—NFKB1—allergic rhinitis	0.000524	0.00501	CbGpPWpGaD
Trametinib—MAP2K2—IL-1 signaling pathway—NFKB1—allergic rhinitis	0.000524	0.00501	CbGpPWpGaD
Trametinib—MAP2K2—Interleukin-11 Signaling Pathway—TGFB1—allergic rhinitis	0.000522	0.00499	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—MS4A2—allergic rhinitis	0.000514	0.00491	CbGpPWpGaD
Trametinib—MAP2K2—TGF-beta Signaling Pathway—SMAD3—allergic rhinitis	0.000512	0.0049	CbGpPWpGaD
Trametinib—MAP2K1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—allergic rhinitis	0.000496	0.00474	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—HLA-G—allergic rhinitis	0.000494	0.00473	CbGpPWpGaD
Trametinib—MAP2K1—IL-1 signaling pathway—NFKB1—allergic rhinitis	0.00049	0.00469	CbGpPWpGaD
Trametinib—MAP2K1—RANKL/RANK Signaling Pathway—NFKB1—allergic rhinitis	0.00049	0.00469	CbGpPWpGaD
Trametinib—MAP2K1—Cardiac Hypertrophic Response—NFKB1—allergic rhinitis	0.00049	0.00469	CbGpPWpGaD
Trametinib—MAP2K1—Interleukin-11 Signaling Pathway—TGFB1—allergic rhinitis	0.000488	0.00467	CbGpPWpGaD
Trametinib—MAP2K2—Fc-epsilon receptor I signaling in mast cells—NFKB1—allergic rhinitis	0.000483	0.00461	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—MS4A2—allergic rhinitis	0.00048	0.00459	CbGpPWpGaD
Trametinib—MAP2K1—TGF-beta Signaling Pathway—SMAD3—allergic rhinitis	0.000479	0.00458	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—HLA-G—allergic rhinitis	0.000463	0.00442	CbGpPWpGaD
Trametinib—MAP2K2—Oncostatin M Signaling Pathway—NFKB1—allergic rhinitis	0.000459	0.00439	CbGpPWpGaD
Trametinib—MAP2K1—Fc-epsilon receptor I signaling in mast cells—NFKB1—allergic rhinitis	0.000452	0.00432	CbGpPWpGaD
Trametinib—MAP2K1—IL-3 Signaling Pathway—TGFB1—allergic rhinitis	0.000448	0.00429	CbGpPWpGaD
Trametinib—MAP2K2—Cardiac Hypertrophic Response—TGFB1—allergic rhinitis	0.000437	0.00418	CbGpPWpGaD
Trametinib—MAP2K1—Oncostatin M Signaling Pathway—NFKB1—allergic rhinitis	0.000429	0.0041	CbGpPWpGaD
Trametinib—MAP2K1—AGE/RAGE pathway—NFKB1—allergic rhinitis	0.000424	0.00405	CbGpPWpGaD
Trametinib—MAP2K1—BCR signaling pathway—NFKB1—allergic rhinitis	0.000419	0.00401	CbGpPWpGaD
Trametinib—MAP2K2—TCR Signaling Pathway—CD4—allergic rhinitis	0.00041	0.00392	CbGpPWpGaD
Trametinib—MAP2K2—TRAF6 Mediated Induction of proinflammatory cytokines—NFKB1—allergic rhinitis	0.000409	0.00391	CbGpPWpGaD
Trametinib—MAP2K2—Leptin signaling pathway—NFKB1—allergic rhinitis	0.000409	0.00391	CbGpPWpGaD
Trametinib—MAP2K1—Cardiac Hypertrophic Response—TGFB1—allergic rhinitis	0.000409	0.00391	CbGpPWpGaD
Trametinib—Dry skin—Hydrocortisone—allergic rhinitis	0.000402	0.00155	CcSEcCtD
Trametinib—Abdominal pain upper—Hydrocortisone—allergic rhinitis	0.0004	0.00155	CcSEcCtD
Trametinib—Constipation—Flunisolide—allergic rhinitis	0.0004	0.00154	CcSEcCtD
Trametinib—Body temperature increased—Loratadine—allergic rhinitis	0.0004	0.00154	CcSEcCtD
Trametinib—Abdominal pain—Loratadine—allergic rhinitis	0.0004	0.00154	CcSEcCtD
Trametinib—Oedema—Montelukast—allergic rhinitis	0.000399	0.00154	CcSEcCtD
Trametinib—Hypokalaemia—Hydrocortisone—allergic rhinitis	0.000399	0.00154	CcSEcCtD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—IL5—allergic rhinitis	0.000399	0.00381	CbGpPWpGaD
Trametinib—Nausea—Olopatadine—allergic rhinitis	0.000398	0.00154	CcSEcCtD
Trametinib—Infection—Montelukast—allergic rhinitis	0.000396	0.00153	CcSEcCtD
Trametinib—Nervous system disorder—Montelukast—allergic rhinitis	0.000391	0.00151	CcSEcCtD
Trametinib—Thrombocytopenia—Montelukast—allergic rhinitis	0.000391	0.00151	CcSEcCtD
Trametinib—Nausea—Diphenhydramine—allergic rhinitis	0.00039	0.00151	CcSEcCtD
Trametinib—Nausea—Dimenhydrinate—allergic rhinitis	0.00039	0.00151	CcSEcCtD
Trametinib—Gastrointestinal pain—Cetirizine—allergic rhinitis	0.000389	0.0015	CcSEcCtD
Trametinib—Skin disorder—Montelukast—allergic rhinitis	0.000387	0.0015	CcSEcCtD
Trametinib—Alanine aminotransferase increased—Hydrocortisone—allergic rhinitis	0.000387	0.00149	CcSEcCtD
Trametinib—MAP2K1—TCR Signaling Pathway—CD4—allergic rhinitis	0.000384	0.00367	CbGpPWpGaD
Trametinib—MAP2K1—Leptin signaling pathway—NFKB1—allergic rhinitis	0.000383	0.00366	CbGpPWpGaD
Trametinib—MAP2K1—TRAF6 Mediated Induction of proinflammatory cytokines—NFKB1—allergic rhinitis	0.000383	0.00366	CbGpPWpGaD
Trametinib—Gastrointestinal pain—Flunisolide—allergic rhinitis	0.000382	0.00148	CcSEcCtD
Trametinib—Pancreatitis—Prednisolone—allergic rhinitis	0.00038	0.00147	CcSEcCtD
Trametinib—Body temperature increased—Cetirizine—allergic rhinitis	0.000376	0.00145	CcSEcCtD
Trametinib—Abdominal pain—Cetirizine—allergic rhinitis	0.000376	0.00145	CcSEcCtD
Trametinib—MAP2K2—MicroRNAs in cardiomyocyte hypertrophy—NFKB1—allergic rhinitis	0.000374	0.00357	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—IL5—allergic rhinitis	0.000373	0.00357	CbGpPWpGaD
Trametinib—Pancreatitis—Hydrocortisone—allergic rhinitis	0.000371	0.00143	CcSEcCtD
Trametinib—MAP2K2—MyD88 cascade initiated on plasma membrane—NFKB1—allergic rhinitis	0.00037	0.00354	CbGpPWpGaD
Trametinib—Body temperature increased—Flunisolide—allergic rhinitis	0.00037	0.00143	CcSEcCtD
Trametinib—Abdominal pain—Flunisolide—allergic rhinitis	0.00037	0.00143	CcSEcCtD
Trametinib—MAP2K2—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NFKB1—allergic rhinitis	0.000367	0.00351	CbGpPWpGaD
Trametinib—Musculoskeletal discomfort—Montelukast—allergic rhinitis	0.000363	0.0014	CcSEcCtD
Trametinib—Alanine aminotransferase increased—Methylprednisolone—allergic rhinitis	0.000363	0.0014	CcSEcCtD
Trametinib—Asthenia—Loratadine—allergic rhinitis	0.000363	0.0014	CcSEcCtD
Trametinib—Insomnia—Montelukast—allergic rhinitis	0.000361	0.00139	CcSEcCtD
Trametinib—MAP2K2—MyD88 dependent cascade initiated on endosome—NFKB1—allergic rhinitis	0.00036	0.00344	CbGpPWpGaD
Trametinib—MAP2K2—TCR Signaling Pathway—NFKB1—allergic rhinitis	0.000354	0.00338	CbGpPWpGaD
Trametinib—Pancreatitis—Triamcinolone—allergic rhinitis	0.00035	0.00135	CcSEcCtD
Trametinib—MAP2K1—MicroRNAs in cardiomyocyte hypertrophy—NFKB1—allergic rhinitis	0.00035	0.00334	CbGpPWpGaD
Trametinib—Pancreatitis—Methylprednisolone—allergic rhinitis	0.000349	0.00135	CcSEcCtD
Trametinib—MAP2K2—Toll Like Receptor 9 (TLR9) Cascade—NFKB1—allergic rhinitis	0.000347	0.00332	CbGpPWpGaD
Trametinib—MAP2K1—MyD88 cascade initiated on plasma membrane—NFKB1—allergic rhinitis	0.000346	0.00331	CbGpPWpGaD
Trametinib—Diarrhoea—Loratadine—allergic rhinitis	0.000346	0.00134	CcSEcCtD
Trametinib—Gastrointestinal disorder—Montelukast—allergic rhinitis	0.000344	0.00133	CcSEcCtD
Trametinib—Fatigue—Montelukast—allergic rhinitis	0.000344	0.00133	CcSEcCtD
Trametinib—Dry skin—Dexamethasone—allergic rhinitis	0.000343	0.00133	CcSEcCtD
Trametinib—Dry skin—Betamethasone—allergic rhinitis	0.000343	0.00133	CcSEcCtD
Trametinib—MAP2K1—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NFKB1—allergic rhinitis	0.000343	0.00328	CbGpPWpGaD
Trametinib—MAP2K2—MyD88:Mal cascade initiated on plasma membrane—NFKB1—allergic rhinitis	0.000341	0.00327	CbGpPWpGaD
Trametinib—Asthenia—Cetirizine—allergic rhinitis	0.000341	0.00132	CcSEcCtD
Trametinib—Hypokalaemia—Betamethasone—allergic rhinitis	0.000341	0.00132	CcSEcCtD
Trametinib—Hypokalaemia—Dexamethasone—allergic rhinitis	0.000341	0.00132	CcSEcCtD
Trametinib—Infestation—Hydrocortisone—allergic rhinitis	0.000338	0.0013	CcSEcCtD
Trametinib—Infestation NOS—Hydrocortisone—allergic rhinitis	0.000338	0.0013	CcSEcCtD
Trametinib—MAP2K1—MyD88 dependent cascade initiated on endosome—NFKB1—allergic rhinitis	0.000337	0.00322	CbGpPWpGaD
Trametinib—Pruritus—Cetirizine—allergic rhinitis	0.000337	0.0013	CcSEcCtD
Trametinib—Asthenia—Flunisolide—allergic rhinitis	0.000336	0.0013	CcSEcCtD
Trametinib—Dizziness—Loratadine—allergic rhinitis	0.000334	0.00129	CcSEcCtD
Trametinib—MAP2K2—B Cell Receptor Signaling Pathway—NFKB1—allergic rhinitis	0.000333	0.00318	CbGpPWpGaD
Trametinib—Pruritus—Flunisolide—allergic rhinitis	0.000331	0.00128	CcSEcCtD
Trametinib—MAP2K1—TCR Signaling Pathway—NFKB1—allergic rhinitis	0.000331	0.00316	CbGpPWpGaD
Trametinib—MAP2K2—MyD88-independent cascade—NFKB1—allergic rhinitis	0.000328	0.00313	CbGpPWpGaD
Trametinib—Gastrointestinal pain—Montelukast—allergic rhinitis	0.000326	0.00126	CcSEcCtD
Trametinib—Diarrhoea—Cetirizine—allergic rhinitis	0.000325	0.00126	CcSEcCtD
Trametinib—MAP2K1—Toll Like Receptor 9 (TLR9) Cascade—NFKB1—allergic rhinitis	0.000325	0.00311	CbGpPWpGaD
Trametinib—MAP2K1—Corticotropin-releasing hormone—NFKB1—allergic rhinitis	0.000325	0.00311	CbGpPWpGaD
Trametinib—Vomiting—Loratadine—allergic rhinitis	0.000321	0.00124	CcSEcCtD
Trametinib—Diarrhoea—Flunisolide—allergic rhinitis	0.00032	0.00124	CcSEcCtD
Trametinib—MAP2K2—Toll-like Receptor Signaling Pathway—NFKB1—allergic rhinitis	0.00032	0.00306	CbGpPWpGaD
Trametinib—MAP2K1—MyD88:Mal cascade initiated on plasma membrane—NFKB1—allergic rhinitis	0.000319	0.00305	CbGpPWpGaD
Trametinib—Rash—Loratadine—allergic rhinitis	0.000319	0.00123	CcSEcCtD
Trametinib—Dermatitis—Loratadine—allergic rhinitis	0.000318	0.00123	CcSEcCtD
Trametinib—Infestation NOS—Methylprednisolone—allergic rhinitis	0.000317	0.00123	CcSEcCtD
Trametinib—Infestation—Methylprednisolone—allergic rhinitis	0.000317	0.00123	CcSEcCtD
Trametinib—Headache—Loratadine—allergic rhinitis	0.000317	0.00122	CcSEcCtD
Trametinib—Bradycardia—Prednisolone—allergic rhinitis	0.000316	0.00122	CcSEcCtD
Trametinib—Abdominal pain—Montelukast—allergic rhinitis	0.000315	0.00122	CcSEcCtD
Trametinib—Body temperature increased—Montelukast—allergic rhinitis	0.000315	0.00122	CcSEcCtD
Trametinib—Dizziness—Cetirizine—allergic rhinitis	0.000315	0.00121	CcSEcCtD
Trametinib—Haemoglobin—Prednisolone—allergic rhinitis	0.000312	0.0012	CcSEcCtD
Trametinib—MAP2K1—B Cell Receptor Signaling Pathway—NFKB1—allergic rhinitis	0.000312	0.00298	CbGpPWpGaD
Trametinib—MAP2K2—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—allergic rhinitis	0.000311	0.00298	CbGpPWpGaD
Trametinib—Haemorrhage—Prednisolone—allergic rhinitis	0.00031	0.0012	CcSEcCtD
Trametinib—Dizziness—Flunisolide—allergic rhinitis	0.000309	0.00119	CcSEcCtD
Trametinib—Bradycardia—Hydrocortisone—allergic rhinitis	0.000309	0.00119	CcSEcCtD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—HLA-DQB1—allergic rhinitis	0.000309	0.00295	CbGpPWpGaD
Trametinib—MAP2K1—MyD88-independent cascade—NFKB1—allergic rhinitis	0.000306	0.00293	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by Interleukins—NFKB1—allergic rhinitis	0.000306	0.00292	CbGpPWpGaD
Trametinib—Haemoglobin—Hydrocortisone—allergic rhinitis	0.000305	0.00118	CcSEcCtD
Trametinib—Haemorrhage—Hydrocortisone—allergic rhinitis	0.000303	0.00117	CcSEcCtD
Trametinib—Vomiting—Cetirizine—allergic rhinitis	0.000302	0.00117	CcSEcCtD
Trametinib—Nausea—Loratadine—allergic rhinitis	0.0003	0.00116	CcSEcCtD
Trametinib—Epistaxis—Triamcinolone—allergic rhinitis	0.0003	0.00116	CcSEcCtD
Trametinib—Rash—Cetirizine—allergic rhinitis	0.0003	0.00116	CcSEcCtD
Trametinib—Dermatitis—Cetirizine—allergic rhinitis	0.0003	0.00116	CcSEcCtD
Trametinib—MAP2K1—Toll-like Receptor Signaling Pathway—NFKB1—allergic rhinitis	0.000299	0.00286	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—MS4A2—allergic rhinitis	0.000299	0.00286	CbGpPWpGaD
Trametinib—Headache—Cetirizine—allergic rhinitis	0.000298	0.00115	CcSEcCtD
Trametinib—Connective tissue disorder—Hydrocortisone—allergic rhinitis	0.000298	0.00115	CcSEcCtD
Trametinib—Vomiting—Flunisolide—allergic rhinitis	0.000297	0.00115	CcSEcCtD
Trametinib—Rash—Flunisolide—allergic rhinitis	0.000295	0.00114	CcSEcCtD
Trametinib—MAP2K2—Activated TLR4 signalling—NFKB1—allergic rhinitis	0.000295	0.00282	CbGpPWpGaD
Trametinib—Dermatitis—Flunisolide—allergic rhinitis	0.000295	0.00114	CcSEcCtD
Trametinib—MAP2K2—TCR Signaling Pathway—TGFB1—allergic rhinitis	0.000295	0.00282	CbGpPWpGaD
Trametinib—Headache—Flunisolide—allergic rhinitis	0.000293	0.00113	CcSEcCtD
Trametinib—Hyperglycaemia—Dexamethasone—allergic rhinitis	0.000292	0.00113	CcSEcCtD
Trametinib—Hyperglycaemia—Betamethasone—allergic rhinitis	0.000292	0.00113	CcSEcCtD
Trametinib—MAP2K1—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—allergic rhinitis	0.000291	0.00278	CbGpPWpGaD
Trametinib—Bradycardia—Triamcinolone—allergic rhinitis	0.000291	0.00112	CcSEcCtD
Trametinib—Bradycardia—Methylprednisolone—allergic rhinitis	0.00029	0.00112	CcSEcCtD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—HLA-DQB1—allergic rhinitis	0.000289	0.00276	CbGpPWpGaD
Trametinib—Haemoglobin—Triamcinolone—allergic rhinitis	0.000287	0.00111	CcSEcCtD
Trametinib—Haemoglobin—Methylprednisolone—allergic rhinitis	0.000286	0.00111	CcSEcCtD
Trametinib—Asthenia—Montelukast—allergic rhinitis	0.000286	0.00111	CcSEcCtD
Trametinib—MAP2K1—Signaling by Interleukins—NFKB1—allergic rhinitis	0.000286	0.00273	CbGpPWpGaD
Trametinib—Haemorrhage—Triamcinolone—allergic rhinitis	0.000286	0.0011	CcSEcCtD
Trametinib—Haemorrhage—Methylprednisolone—allergic rhinitis	0.000285	0.0011	CcSEcCtD
Trametinib—Eye disorder—Hydrocortisone—allergic rhinitis	0.000283	0.00109	CcSEcCtD
Trametinib—Nausea—Cetirizine—allergic rhinitis	0.000283	0.00109	CcSEcCtD
Trametinib—Pruritus—Montelukast—allergic rhinitis	0.000282	0.00109	CcSEcCtD
Trametinib—Connective tissue disorder—Methylprednisolone—allergic rhinitis	0.00028	0.00108	CcSEcCtD
Trametinib—MAP2K1—Immune System—MS4A2—allergic rhinitis	0.00028	0.00268	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—PTGDR2—allergic rhinitis	0.000278	0.00266	CbGpPWpGaD
Trametinib—Nausea—Flunisolide—allergic rhinitis	0.000278	0.00107	CcSEcCtD
Trametinib—Arrhythmia—Prednisolone—allergic rhinitis	0.000277	0.00107	CcSEcCtD
Trametinib—MAP2K2—Toll Like Receptor 4 (TLR4) Cascade—NFKB1—allergic rhinitis	0.000277	0.00265	CbGpPWpGaD
Trametinib—MAP2K1—Activated TLR4 signalling—NFKB1—allergic rhinitis	0.000276	0.00264	CbGpPWpGaD
Trametinib—MAP2K1—TCR Signaling Pathway—TGFB1—allergic rhinitis	0.000276	0.00263	CbGpPWpGaD
Trametinib—Diarrhoea—Montelukast—allergic rhinitis	0.000273	0.00105	CcSEcCtD
Trametinib—Arrhythmia—Hydrocortisone—allergic rhinitis	0.000271	0.00105	CcSEcCtD
Trametinib—MAP2K1—Corticotropin-releasing hormone—TGFB1—allergic rhinitis	0.000271	0.00259	CbGpPWpGaD
Trametinib—Erythema—Prednisolone—allergic rhinitis	0.00027	0.00104	CcSEcCtD
Trametinib—Eye disorder—Methylprednisolone—allergic rhinitis	0.000266	0.00103	CcSEcCtD
Trametinib—Mental disorder—Hydrocortisone—allergic rhinitis	0.000266	0.00103	CcSEcCtD
Trametinib—Cardiac disorder—Methylprednisolone—allergic rhinitis	0.000264	0.00102	CcSEcCtD
Trametinib—Malnutrition—Hydrocortisone—allergic rhinitis	0.000264	0.00102	CcSEcCtD
Trametinib—Erythema—Hydrocortisone—allergic rhinitis	0.000264	0.00102	CcSEcCtD
Trametinib—Dizziness—Montelukast—allergic rhinitis	0.000264	0.00102	CcSEcCtD
Trametinib—Bradycardia—Betamethasone—allergic rhinitis	0.000264	0.00102	CcSEcCtD
Trametinib—Bradycardia—Dexamethasone—allergic rhinitis	0.000264	0.00102	CcSEcCtD
Trametinib—MAP2K1—Signaling by GPCR—PTGDR2—allergic rhinitis	0.00026	0.00249	CbGpPWpGaD
Trametinib—Haemoglobin—Betamethasone—allergic rhinitis	0.00026	0.00101	CcSEcCtD
Trametinib—Haemoglobin—Dexamethasone—allergic rhinitis	0.00026	0.00101	CcSEcCtD
Trametinib—MAP2K1—Toll Like Receptor 4 (TLR4) Cascade—NFKB1—allergic rhinitis	0.000259	0.00248	CbGpPWpGaD
Trametinib—Haemorrhage—Betamethasone—allergic rhinitis	0.000259	0.001	CcSEcCtD
Trametinib—Haemorrhage—Dexamethasone—allergic rhinitis	0.000259	0.001	CcSEcCtD
Trametinib—Angiopathy—Methylprednisolone—allergic rhinitis	0.000258	0.000998	CcSEcCtD
Trametinib—Mediastinal disorder—Methylprednisolone—allergic rhinitis	0.000257	0.000991	CcSEcCtD
Trametinib—Arrhythmia—Triamcinolone—allergic rhinitis	0.000255	0.000985	CcSEcCtD
Trametinib—Vision blurred—Prednisolone—allergic rhinitis	0.000255	0.000983	CcSEcCtD
Trametinib—Arrhythmia—Methylprednisolone—allergic rhinitis	0.000254	0.000983	CcSEcCtD
Trametinib—Vomiting—Montelukast—allergic rhinitis	0.000254	0.000979	CcSEcCtD
Trametinib—Rash—Montelukast—allergic rhinitis	0.000252	0.000971	CcSEcCtD
Trametinib—Dermatitis—Montelukast—allergic rhinitis	0.000251	0.00097	CcSEcCtD
Trametinib—Headache—Montelukast—allergic rhinitis	0.00025	0.000965	CcSEcCtD
Trametinib—MAP2K2—Regulation of toll-like receptor signaling pathway—NFKB1—allergic rhinitis	0.00025	0.00239	CbGpPWpGaD
Trametinib—Mental disorder—Methylprednisolone—allergic rhinitis	0.00025	0.000964	CcSEcCtD
Trametinib—Erythema—Triamcinolone—allergic rhinitis	0.000249	0.00096	CcSEcCtD
Trametinib—Erythema—Methylprednisolone—allergic rhinitis	0.000248	0.000957	CcSEcCtD
Trametinib—Malnutrition—Methylprednisolone—allergic rhinitis	0.000248	0.000957	CcSEcCtD
Trametinib—MAP2K2—Toll-Like Receptors Cascades—NFKB1—allergic rhinitis	0.000247	0.00236	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—ADIPOQ—allergic rhinitis	0.000245	0.00234	CbGpPWpGaD
Trametinib—MAP2K1—Senescence and Autophagy in Cancer—TGFB1—allergic rhinitis	0.000244	0.00233	CbGpPWpGaD
Trametinib—Dysgeusia—Triamcinolone—allergic rhinitis	0.000243	0.00094	CcSEcCtD
Trametinib—MAP2K2—BDNF signaling pathway—NFKB1—allergic rhinitis	0.000243	0.00232	CbGpPWpGaD
Trametinib—Eye disorder—Betamethasone—allergic rhinitis	0.000242	0.000935	CcSEcCtD
Trametinib—Eye disorder—Dexamethasone—allergic rhinitis	0.000242	0.000935	CcSEcCtD
Trametinib—Back pain—Triamcinolone—allergic rhinitis	0.00024	0.000928	CcSEcCtD
Trametinib—Nausea—Montelukast—allergic rhinitis	0.000237	0.000915	CcSEcCtD
Trametinib—Angiopathy—Betamethasone—allergic rhinitis	0.000235	0.000907	CcSEcCtD
Trametinib—Angiopathy—Dexamethasone—allergic rhinitis	0.000235	0.000907	CcSEcCtD
Trametinib—MAP2K1—Regulation of toll-like receptor signaling pathway—NFKB1—allergic rhinitis	0.000234	0.00223	CbGpPWpGaD
Trametinib—Hypertension—Prednisolone—allergic rhinitis	0.000233	0.000901	CcSEcCtD
Trametinib—Arrhythmia—Betamethasone—allergic rhinitis	0.000231	0.000893	CcSEcCtD
Trametinib—Arrhythmia—Dexamethasone—allergic rhinitis	0.000231	0.000893	CcSEcCtD
Trametinib—MAP2K1—Toll-Like Receptors Cascades—NFKB1—allergic rhinitis	0.000231	0.00221	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—ADIPOQ—allergic rhinitis	0.000229	0.00219	CbGpPWpGaD
Trametinib—Hypertension—Hydrocortisone—allergic rhinitis	0.000228	0.00088	CcSEcCtD
Trametinib—MAP2K1—BDNF signaling pathway—NFKB1—allergic rhinitis	0.000227	0.00217	CbGpPWpGaD
Trametinib—Erythema—Dexamethasone—allergic rhinitis	0.000226	0.000871	CcSEcCtD
Trametinib—Erythema—Betamethasone—allergic rhinitis	0.000226	0.000871	CcSEcCtD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—ICAM1—allergic rhinitis	0.000225	0.00215	CbGpPWpGaD
Trametinib—Myalgia—Hydrocortisone—allergic rhinitis	0.000225	0.000868	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—allergic rhinitis	0.000223	0.000862	CcSEcCtD
Trametinib—Oedema—Prednisolone—allergic rhinitis	0.000221	0.000852	CcSEcCtD
Trametinib—MAP2K2—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.000218	0.00209	CbGpPWpGaD
Trametinib—Cough—Triamcinolone—allergic rhinitis	0.000217	0.000837	CcSEcCtD
Trametinib—MAP2K2—TGF-beta Signaling Pathway—TGFB1—allergic rhinitis	0.000217	0.00207	CbGpPWpGaD
Trametinib—Oedema—Hydrocortisone—allergic rhinitis	0.000215	0.000832	CcSEcCtD
Trametinib—MAP2K2—MAPK Signaling Pathway—NFKB1—allergic rhinitis	0.000215	0.00205	CbGpPWpGaD
Trametinib—Hypertension—Triamcinolone—allergic rhinitis	0.000215	0.000828	CcSEcCtD
Trametinib—Hypertension—Methylprednisolone—allergic rhinitis	0.000214	0.000827	CcSEcCtD
Trametinib—Infection—Hydrocortisone—allergic rhinitis	0.000214	0.000826	CcSEcCtD
Trametinib—Hyperhidrosis—Prednisolone—allergic rhinitis	0.000213	0.000823	CcSEcCtD
Trametinib—Myalgia—Triamcinolone—allergic rhinitis	0.000212	0.000817	CcSEcCtD
Trametinib—Nervous system disorder—Hydrocortisone—allergic rhinitis	0.000211	0.000816	CcSEcCtD
Trametinib—Arthralgia—Methylprednisolone—allergic rhinitis	0.000211	0.000815	CcSEcCtD
Trametinib—Myalgia—Methylprednisolone—allergic rhinitis	0.000211	0.000815	CcSEcCtD
Trametinib—MAP2K2—Signaling by GPCR—CCL11—allergic rhinitis	0.000211	0.00202	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—ICAM1—allergic rhinitis	0.000211	0.00202	CbGpPWpGaD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—allergic rhinitis	0.00021	0.000809	CcSEcCtD
Trametinib—Skin disorder—Hydrocortisone—allergic rhinitis	0.000209	0.000808	CcSEcCtD
Trametinib—Hyperhidrosis—Hydrocortisone—allergic rhinitis	0.000208	0.000804	CcSEcCtD
Trametinib—Dry mouth—Triamcinolone—allergic rhinitis	0.000207	0.000799	CcSEcCtD
Trametinib—MAP2K2—Fc epsilon receptor (FCERI) signaling—NFKB1—allergic rhinitis	0.000206	0.00197	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.000204	0.00195	CbGpPWpGaD
Trametinib—Oedema—Triamcinolone—allergic rhinitis	0.000203	0.000783	CcSEcCtD
Trametinib—MAP2K1—TGF-beta Signaling Pathway—TGFB1—allergic rhinitis	0.000203	0.00194	CbGpPWpGaD
Trametinib—Infection—Triamcinolone—allergic rhinitis	0.000202	0.000778	CcSEcCtD
Trametinib—Infection—Methylprednisolone—allergic rhinitis	0.000201	0.000776	CcSEcCtD
Trametinib—MAP2K1—MAPK Signaling Pathway—NFKB1—allergic rhinitis	0.000201	0.00192	CbGpPWpGaD
Trametinib—Insomnia—Prednisolone—allergic rhinitis	0.000199	0.00077	CcSEcCtD
Trametinib—Nervous system disorder—Methylprednisolone—allergic rhinitis	0.000198	0.000766	CcSEcCtD
Trametinib—MAP2K1—Signaling by GPCR—CCL11—allergic rhinitis	0.000197	0.00189	CbGpPWpGaD
Trametinib—Skin disorder—Methylprednisolone—allergic rhinitis	0.000197	0.000759	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Hydrocortisone—allergic rhinitis	0.000196	0.000758	CcSEcCtD
Trametinib—Hyperhidrosis—Triamcinolone—allergic rhinitis	0.000196	0.000757	CcSEcCtD
Trametinib—Hyperhidrosis—Methylprednisolone—allergic rhinitis	0.000196	0.000755	CcSEcCtD
Trametinib—Insomnia—Hydrocortisone—allergic rhinitis	0.000195	0.000752	CcSEcCtD
Trametinib—Hypertension—Betamethasone—allergic rhinitis	0.000195	0.000752	CcSEcCtD
Trametinib—Hypertension—Dexamethasone—allergic rhinitis	0.000195	0.000752	CcSEcCtD
Trametinib—MAP2K1—Fc epsilon receptor (FCERI) signaling—NFKB1—allergic rhinitis	0.000193	0.00184	CbGpPWpGaD
Trametinib—Myalgia—Dexamethasone—allergic rhinitis	0.000192	0.000741	CcSEcCtD
Trametinib—Myalgia—Betamethasone—allergic rhinitis	0.000192	0.000741	CcSEcCtD
Trametinib—Decreased appetite—Hydrocortisone—allergic rhinitis	0.000187	0.000723	CcSEcCtD
Trametinib—Gastrointestinal disorder—Hydrocortisone—allergic rhinitis	0.000186	0.000718	CcSEcCtD
Trametinib—Fatigue—Hydrocortisone—allergic rhinitis	0.000186	0.000717	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Triamcinolone—allergic rhinitis	0.000185	0.000713	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Methylprednisolone—allergic rhinitis	0.000184	0.000712	CcSEcCtD
Trametinib—Oedema—Dexamethasone—allergic rhinitis	0.000184	0.000711	CcSEcCtD
Trametinib—Oedema—Betamethasone—allergic rhinitis	0.000184	0.000711	CcSEcCtD
Trametinib—Insomnia—Triamcinolone—allergic rhinitis	0.000183	0.000708	CcSEcCtD
Trametinib—Insomnia—Methylprednisolone—allergic rhinitis	0.000183	0.000707	CcSEcCtD
Trametinib—Infection—Dexamethasone—allergic rhinitis	0.000183	0.000706	CcSEcCtD
Trametinib—Infection—Betamethasone—allergic rhinitis	0.000183	0.000706	CcSEcCtD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	0.000181	0.00173	CbGpPWpGaD
Trametinib—Nervous system disorder—Dexamethasone—allergic rhinitis	0.00018	0.000697	CcSEcCtD
Trametinib—Nervous system disorder—Betamethasone—allergic rhinitis	0.00018	0.000697	CcSEcCtD
Trametinib—Thrombocytopenia—Dexamethasone—allergic rhinitis	0.00018	0.000696	CcSEcCtD
Trametinib—Thrombocytopenia—Betamethasone—allergic rhinitis	0.00018	0.000696	CcSEcCtD
Trametinib—MAP2K2—MAPK Signaling Pathway—TGFB1—allergic rhinitis	0.000179	0.00171	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—SMAD3—allergic rhinitis	0.000178	0.0017	CbGpPWpGaD
Trametinib—Hyperhidrosis—Dexamethasone—allergic rhinitis	0.000178	0.000687	CcSEcCtD
Trametinib—Hyperhidrosis—Betamethasone—allergic rhinitis	0.000178	0.000687	CcSEcCtD
Trametinib—Gastrointestinal pain—Hydrocortisone—allergic rhinitis	0.000176	0.00068	CcSEcCtD
Trametinib—Fatigue—Triamcinolone—allergic rhinitis	0.000175	0.000675	CcSEcCtD
Trametinib—Fatigue—Methylprednisolone—allergic rhinitis	0.000174	0.000674	CcSEcCtD
Trametinib—Body temperature increased—Hydrocortisone—allergic rhinitis	0.00017	0.000657	CcSEcCtD
Trametinib—Abdominal pain—Hydrocortisone—allergic rhinitis	0.00017	0.000657	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Betamethasone—allergic rhinitis	0.000168	0.000647	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Dexamethasone—allergic rhinitis	0.000168	0.000647	CcSEcCtD
Trametinib—MAP2K1—MAPK Signaling Pathway—TGFB1—allergic rhinitis	0.000167	0.0016	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—SMAD3—allergic rhinitis	0.000167	0.00159	CbGpPWpGaD
Trametinib—Insomnia—Dexamethasone—allergic rhinitis	0.000166	0.000643	CcSEcCtD
Trametinib—Insomnia—Betamethasone—allergic rhinitis	0.000166	0.000643	CcSEcCtD
Trametinib—Gastrointestinal pain—Methylprednisolone—allergic rhinitis	0.000165	0.000639	CcSEcCtD
Trametinib—MAP2K2—Signaling Pathways—PTGDR2—allergic rhinitis	0.000164	0.00157	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—HLA-G—allergic rhinitis	0.000162	0.00154	CbGpPWpGaD
Trametinib—Body temperature increased—Triamcinolone—allergic rhinitis	0.00016	0.000619	CcSEcCtD
Trametinib—Abdominal pain—Methylprednisolone—allergic rhinitis	0.00016	0.000618	CcSEcCtD
Trametinib—Decreased appetite—Dexamethasone—allergic rhinitis	0.00016	0.000618	CcSEcCtD
Trametinib—Decreased appetite—Betamethasone—allergic rhinitis	0.00016	0.000618	CcSEcCtD
Trametinib—Gastrointestinal disorder—Betamethasone—allergic rhinitis	0.000159	0.000613	CcSEcCtD
Trametinib—Gastrointestinal disorder—Dexamethasone—allergic rhinitis	0.000159	0.000613	CcSEcCtD
Trametinib—Fatigue—Betamethasone—allergic rhinitis	0.000159	0.000613	CcSEcCtD
Trametinib—Fatigue—Dexamethasone—allergic rhinitis	0.000159	0.000613	CcSEcCtD
Trametinib—Asthenia—Hydrocortisone—allergic rhinitis	0.000155	0.000597	CcSEcCtD
Trametinib—MAP2K1—Signaling Pathways—PTGDR2—allergic rhinitis	0.000154	0.00147	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—TAC1—allergic rhinitis	0.000153	0.00147	CbGpPWpGaD
Trametinib—Pruritus—Hydrocortisone—allergic rhinitis	0.000152	0.000588	CcSEcCtD
Trametinib—MAP2K1—Immune System—HLA-G—allergic rhinitis	0.000151	0.00144	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	0.000151	0.00144	CbGpPWpGaD
Trametinib—Gastrointestinal pain—Betamethasone—allergic rhinitis	0.00015	0.000581	CcSEcCtD
Trametinib—Gastrointestinal pain—Dexamethasone—allergic rhinitis	0.00015	0.000581	CcSEcCtD
Trametinib—Diarrhoea—Hydrocortisone—allergic rhinitis	0.000147	0.000569	CcSEcCtD
Trametinib—Dizziness—Prednisolone—allergic rhinitis	0.000146	0.000563	CcSEcCtD
Trametinib—Asthenia—Triamcinolone—allergic rhinitis	0.000146	0.000562	CcSEcCtD
Trametinib—Abdominal pain—Dexamethasone—allergic rhinitis	0.000145	0.000562	CcSEcCtD
Trametinib—Abdominal pain—Betamethasone—allergic rhinitis	0.000145	0.000562	CcSEcCtD
Trametinib—Body temperature increased—Dexamethasone—allergic rhinitis	0.000145	0.000562	CcSEcCtD
Trametinib—Body temperature increased—Betamethasone—allergic rhinitis	0.000145	0.000562	CcSEcCtD
Trametinib—Asthenia—Methylprednisolone—allergic rhinitis	0.000145	0.000561	CcSEcCtD
Trametinib—Pruritus—Triamcinolone—allergic rhinitis	0.000144	0.000554	CcSEcCtD
Trametinib—MAP2K1—Signaling by GPCR—TAC1—allergic rhinitis	0.000143	0.00137	CbGpPWpGaD
Trametinib—Pruritus—Methylprednisolone—allergic rhinitis	0.000143	0.000553	CcSEcCtD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—NFKB1—allergic rhinitis	0.000143	0.00136	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—IL5—allergic rhinitis	0.000142	0.00136	CbGpPWpGaD
Trametinib—Dizziness—Hydrocortisone—allergic rhinitis	0.000142	0.00055	CcSEcCtD
Trametinib—MAP2K2—Signaling by NGF—NFKB1—allergic rhinitis	0.00014	0.00134	CbGpPWpGaD
Trametinib—Rash—Prednisolone—allergic rhinitis	0.000139	0.000537	CcSEcCtD
Trametinib—Dermatitis—Prednisolone—allergic rhinitis	0.000139	0.000536	CcSEcCtD
Trametinib—Diarrhoea—Methylprednisolone—allergic rhinitis	0.000138	0.000535	CcSEcCtD
Trametinib—Headache—Prednisolone—allergic rhinitis	0.000138	0.000533	CcSEcCtD
Trametinib—Vomiting—Hydrocortisone—allergic rhinitis	0.000137	0.000529	CcSEcCtD
Trametinib—Rash—Hydrocortisone—allergic rhinitis	0.000136	0.000524	CcSEcCtD
Trametinib—Dermatitis—Hydrocortisone—allergic rhinitis	0.000136	0.000524	CcSEcCtD
Trametinib—Headache—Hydrocortisone—allergic rhinitis	0.000135	0.000521	CcSEcCtD
Trametinib—Dizziness—Triamcinolone—allergic rhinitis	0.000134	0.000518	CcSEcCtD
Trametinib—Dizziness—Methylprednisolone—allergic rhinitis	0.000134	0.000517	CcSEcCtD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—NFKB1—allergic rhinitis	0.000133	0.00128	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—IL5—allergic rhinitis	0.000133	0.00127	CbGpPWpGaD
Trametinib—Asthenia—Dexamethasone—allergic rhinitis	0.000132	0.00051	CcSEcCtD
Trametinib—Asthenia—Betamethasone—allergic rhinitis	0.000132	0.00051	CcSEcCtD
Trametinib—MAP2K1—Signaling by NGF—NFKB1—allergic rhinitis	0.000131	0.00125	CbGpPWpGaD
Trametinib—Nausea—Prednisolone—allergic rhinitis	0.000131	0.000506	CcSEcCtD
Trametinib—Pruritus—Dexamethasone—allergic rhinitis	0.00013	0.000503	CcSEcCtD
Trametinib—Pruritus—Betamethasone—allergic rhinitis	0.00013	0.000503	CcSEcCtD
Trametinib—MAP2K2—Immune System—IL5—allergic rhinitis	0.00013	0.00124	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CYSLTR1—allergic rhinitis	0.000129	0.00123	CbGpPWpGaD
Trametinib—Vomiting—Triamcinolone—allergic rhinitis	0.000129	0.000498	CcSEcCtD
Trametinib—Vomiting—Methylprednisolone—allergic rhinitis	0.000129	0.000497	CcSEcCtD
Trametinib—Nausea—Hydrocortisone—allergic rhinitis	0.000128	0.000494	CcSEcCtD
Trametinib—Rash—Triamcinolone—allergic rhinitis	0.000128	0.000494	CcSEcCtD
Trametinib—Dermatitis—Triamcinolone—allergic rhinitis	0.000128	0.000493	CcSEcCtD
Trametinib—Rash—Methylprednisolone—allergic rhinitis	0.000128	0.000493	CcSEcCtD
Trametinib—Dermatitis—Methylprednisolone—allergic rhinitis	0.000127	0.000492	CcSEcCtD
Trametinib—Headache—Triamcinolone—allergic rhinitis	0.000127	0.000491	CcSEcCtD
Trametinib—Headache—Methylprednisolone—allergic rhinitis	0.000127	0.00049	CcSEcCtD
Trametinib—Diarrhoea—Dexamethasone—allergic rhinitis	0.000126	0.000486	CcSEcCtD
Trametinib—Diarrhoea—Betamethasone—allergic rhinitis	0.000126	0.000486	CcSEcCtD
Trametinib—MAP2K2—Signaling Pathways—CCL11—allergic rhinitis	0.000125	0.00119	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL5—allergic rhinitis	0.000122	0.00116	CbGpPWpGaD
Trametinib—Dizziness—Dexamethasone—allergic rhinitis	0.000122	0.00047	CcSEcCtD
Trametinib—Dizziness—Betamethasone—allergic rhinitis	0.000122	0.00047	CcSEcCtD
Trametinib—MAP2K1—Signaling Pathways—CYSLTR1—allergic rhinitis	0.000121	0.00115	CbGpPWpGaD
Trametinib—Nausea—Triamcinolone—allergic rhinitis	0.00012	0.000465	CcSEcCtD
Trametinib—Nausea—Methylprednisolone—allergic rhinitis	0.00012	0.000464	CcSEcCtD
Trametinib—Vomiting—Betamethasone—allergic rhinitis	0.000117	0.000452	CcSEcCtD
Trametinib—Vomiting—Dexamethasone—allergic rhinitis	0.000117	0.000452	CcSEcCtD
Trametinib—MAP2K1—Signaling Pathways—CCL11—allergic rhinitis	0.000117	0.00111	CbGpPWpGaD
Trametinib—Rash—Dexamethasone—allergic rhinitis	0.000116	0.000448	CcSEcCtD
Trametinib—Rash—Betamethasone—allergic rhinitis	0.000116	0.000448	CcSEcCtD
Trametinib—Dermatitis—Dexamethasone—allergic rhinitis	0.000116	0.000448	CcSEcCtD
Trametinib—Dermatitis—Betamethasone—allergic rhinitis	0.000116	0.000448	CcSEcCtD
Trametinib—Headache—Dexamethasone—allergic rhinitis	0.000115	0.000445	CcSEcCtD
Trametinib—Headache—Betamethasone—allergic rhinitis	0.000115	0.000445	CcSEcCtD
Trametinib—Nausea—Betamethasone—allergic rhinitis	0.000109	0.000422	CcSEcCtD
Trametinib—Nausea—Dexamethasone—allergic rhinitis	0.000109	0.000422	CcSEcCtD
Trametinib—MAP2K2—Immune System—HLA-DQB1—allergic rhinitis	0.000101	0.000964	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—HLA-DQB1—allergic rhinitis	9.43e-05	0.000902	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—CD4—allergic rhinitis	9.28e-05	0.000888	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—NFKB1—allergic rhinitis	9.05e-05	0.000866	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TAC1—allergic rhinitis	9.05e-05	0.000866	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—CD4—allergic rhinitis	8.68e-05	0.00083	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—NFKB1—allergic rhinitis	8.47e-05	0.00081	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TAC1—allergic rhinitis	8.47e-05	0.00081	CbGpPWpGaD
Trametinib—MAP2K2—Disease—SMAD3—allergic rhinitis	8.46e-05	0.000809	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IL5—allergic rhinitis	8.42e-05	0.000805	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—NFKB1—allergic rhinitis	8e-05	0.000765	CbGpPWpGaD
Trametinib—MAP2K1—Disease—SMAD3—allergic rhinitis	7.91e-05	0.000757	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IL5—allergic rhinitis	7.87e-05	0.000753	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—TGFB1—allergic rhinitis	7.54e-05	0.000721	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—NFKB1—allergic rhinitis	7.48e-05	0.000715	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—ICAM1—allergic rhinitis	7.36e-05	0.000703	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—TGFB1—allergic rhinitis	7.06e-05	0.000675	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—ICAM1—allergic rhinitis	6.88e-05	0.000658	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—SMAD3—allergic rhinitis	5.92e-05	0.000567	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—SMAD3—allergic rhinitis	5.54e-05	0.00053	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CD4—allergic rhinitis	5.41e-05	0.000517	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CD4—allergic rhinitis	5.06e-05	0.000484	CbGpPWpGaD
Trametinib—MAP2K2—Disease—CD4—allergic rhinitis	4.99e-05	0.000477	CbGpPWpGaD
Trametinib—MAP2K1—Disease—CD4—allergic rhinitis	4.67e-05	0.000447	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—NFKB1—allergic rhinitis	4.66e-05	0.000445	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—NFKB1—allergic rhinitis	4.36e-05	0.000417	CbGpPWpGaD
Trametinib—MAP2K2—Disease—TGFB1—allergic rhinitis	3.58e-05	0.000343	CbGpPWpGaD
Trametinib—MAP2K1—Disease—TGFB1—allergic rhinitis	3.35e-05	0.00032	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NFKB1—allergic rhinitis	3.01e-05	0.000288	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NFKB1—allergic rhinitis	2.82e-05	0.000269	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TGFB1—allergic rhinitis	2.51e-05	0.00024	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TGFB1—allergic rhinitis	2.35e-05	0.000224	CbGpPWpGaD
